Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Verluma Market Revenue Outlook: What CAGR Lies Ahead Through 2030?
The historical expansion was primarily driven by significant progress in nuclear imaging technologies, a rising incidence of colorectal and solid tumors, enhanced access to radiopharmaceuticals, the broadening of oncology diagnostic infrastructure, and increasing clinical adoption of targeted imaging agents.
The growth projected for the forecast period can be attributed to several factors, including the increasing demand for personalized cancer diagnostics, rising investments in nuclear medicine facilities, the expansion of companion diagnostics within oncology, the greater use of molecular imaging in cancer staging, and continuous innovation in radiolabeled antibody fragments.
Key trends anticipated during the forecast period involve the growing adoption of targeted radiolabeled diagnostics, an increasing application of CEA-targeted imaging agents, a rising demand for tools designed for early cancer detection, the expansion of nuclear medicine imaging applications, and the strengthening integration of precision oncology diagnostics.
Get A Free Sample Report With In-Depth Market Insights:
Verluma Market Demand Drivers Opening New Revenue Streams
The growing occurrence of cancer is projected to stimulate the expansion of the verluma market. Cancer encompasses various diseases marked by unchecked proliferation and dissemination of abnormal cells, capable of invading adjacent tissues and potentially migrating to other body parts via blood and lymph systems. The heightened incidence of cancer stems from demographic aging, evolving lifestyles, and the global spread of risk factors. Verluma functions as a therapeutic device leveraging sophisticated technology, such as electromagnetic fields or other non-invasive approaches, to potentially aid in cancer management by targeting and disrupting malignant cell growth, fostering recovery, and augmenting the body’s reaction to other treatments. For example, in 2024, the American Cancer Society, a US-based non-profit cancer advocacy organization, reported approximately 313,510 new cases of breast cancer diagnoses, an increase from the 300,590 cases noted in 2023. Consequently, the rising cancer incidence is fueling the verluma market’s growth. The escalating need for diagnostic imaging procedures is anticipated to drive the expansion of the verluma market. Diagnostic imaging involves diverse medical methodologies employed to generate internal body visuals for clinical examination and medical interventions. The heightened requirement for these procedures is a result of the rising prevalence of chronic conditions, a greater emphasis on early diagnosis and proactive healthcare, and improved healthcare accessibility. Verluma enhances diagnostic imaging by boosting image quality through advanced algorithms, facilitating more precise identification and assessment of medical issues, and improving patient results. As an illustration, in November 2023, the National Health Service, a UK-based government department, reported that England registered 45.0 million imaging tests in the year concluding March 2023, indicating a 2.2% rise from the 44.0 million recorded in 2022. Thus, the increasing demand for diagnostic imaging procedures is propelling the verluma market’s growth.
Verluma Market Segment Trends And Revenue Contributors
The verluma market covered in this report is segmented –
1) By Indication: Cancer, Non-Cancer
2) By Distribution Channel: Hospital Pharmacies, Online Pharmacies
3) By End User: Adult, Geriatric
Verluma Market Competitive Landscape: Which Companies Lead The Industry?
Major companies operating in the verluma market are Boehringer Ingelheim International GmbH
View The Full Verluma Market Report:
Verluma Market Geographic Analysis: Where Is Demand Rising Fastest?
North America was the largest region in the verluma market in 2025. The regions covered in the verluma market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
